A bankruptcy court on Monday allowed the Intas Pharmaceuticals-Shamrock Pharmachemi consortium’s application to acquire Unimark Remedies. Asset Reconstruction Company India Ltd (Arcil) is also part of the consortium...
EQT in talks for a possible $5.80 billion offer for Dechra
Dechra, a British veterinary pharmaceuticals maker, said it had entered into talks with private equity group EQT for a possible offer in a 4.63 billion pounds ($5.80 billion) all-cash deal. Dechra shareholders would...
Glenmark weighs sale of API business to pare debt
Glenmark Pharmaceuticals Ltd is considering selling a majority stake in Glenmark Life Sciences to pare debt, said two people familiar with the development. Kotak Mahindra Capital Co. Ltd has been hired to run the sale...
Nirma Group acquires eye drop maker Stericon Pharma
The Nirma Group has acquired Bengaluru-based Stericon Pharma Pvt Ltd, a maker of eye drops and contact lens solutions. The financial details were not disclosed, but a statement on the private equity (PE) firm...
Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs
Jounce Therapeutics Inc agreed to be acquired by privately held Concentra Biosciences for $96.46 million while spurning a merger deal with British biotech firm Redx Pharma. The new Concentra deal also involves a...
Sun Pharma acquires 60% stake in Vivaldis Health & Foods for ₹143 cr
Drug major Sun Pharmaceutical on Friday announced that it is set to acquire 60 per cent shareholding in Vivaldis Health & Foods for ₹143.30 crore from its existing shareholders, The remaining 40 per cent...
Eris Lifesciences acquires 9 dermatology brands from Dr Reddy’s for Rs 275 cr
Eris Lifesciences on Thursday said it has acquired nine dermatology brands from Dr Reddy’s Laboratories for Rs 275 crore. The acquired brands are largely in cosmetology segments like anti-acne, moisturisers...
Cipla to sell stake in Uganda arm for $25-30 million
Cipla Ltd, and its wholly owned subsidiaries, Cipla (EU) Limited, and Meditab Holdings Limited, have signed a Share Purchase Agreement with Africa Capitalworks SSA 3 for the sale of a 51.18% stake in Cipla Quality...
Pfizer will spend $43 billion to acquire Seagen
Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 per Seagen share. “Together, Pfizer and Seagen seek to accelerate...
Sun Pharma completes acquisition of Concert Pharmaceuticals
Drug major Sun Pharma said it has completed the acquisition of US-based Concert Pharmaceuticals. In January, the Mumbai-based company inked a pact to acquire Concert in a USD 576 million deal. The drug major has...
Pfizer in talks to buy Seagen for likely for more than $30 bln – WSJ
Pfizer Inc is in early talks to acquire drugmaker Seagen Inc, the Wall Street Journal reported late on Sunday, citing people familiar with the matter. Seagen has a market value of some $30 billion and would be expected...
Sun Pharma acquires 26.09% stake in Agatsa Software, 27.39% in Remidio Innovative Solutions
Drug major Sun Pharma has announced that it has acquired a 26.09% stake in Agatsa Software Private Limited, which is in an early-stage digital diagnostic devices company, for ₹30 crore in two tranches. The acquisition...
